Back

Perme ICU Mobility Score as a comprehensive assessment tool of acute-phase rehabilitation is correlated with clinical outcomes in patients after cardiovascular surgery

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardiovascular rehabilitation Cardiovascular Rehabilitation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Ken Ogura

Kitasato University Graduate School of Medical Sciences, Sagamihara (Japan)

6 More presentations in this session

Presentation thumbnail
Access to cardiac rehabilitation programs in patients with acute coronary syndrome: can referral be a step towards improvement? - Insights from a multicentre national registry
Doctor M. Cabral (Leiria, PT)
Abstract Slides
Presentation thumbnail
Association between the changes in walking speed during 6 months after discharge and subsequent prognosis in older patients with heart failure: report from a multicenter prospective cohort study
Mr S. Hanada (Miyakonojo, JP)
Abstract Slides
Presentation thumbnail
Understanding HCP views about delivering a rehabilitation programme for people living with atrial fibrillation
Ms M. Alhotye (Leicester, GB)
Abstract Slides
Presentation thumbnail
Changes in functional capacity after a cardiac rehabilitation program in spain: defining the profile of those who improve
Miss M. Sestayo Fernandez (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Differential associations of emotional and physical domains of the MacNew Heart with changes in 6-minute walking test
Doctor L. Jellestad (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular rehabilitation

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Session
How to prescribe exercise for people with valvular heart disease or hypertension
thumbnail
Congress Presentation
How should we prescribe exercise – and who should do it?
thumbnail
Congress Presentation
Exercise and cardiovascular risk: friend or foe? - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources